Vaxcyte, Inc. — Director's Dealing 2026

Jan 2, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2025-12-31

Reporting Person: Dhaliwal Harpreet S. (Chief Technical Ops Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-31	Common Stock	S	9743	$46.689	Disposed	23928	Direct

Footnotes

F1: The price reported is a weighted-average price. The shares were sold at prices ranging from $46.42 to $47.155. The reporting person will provide upon request to the SEC, the issuer or security holder of the
issuer, full information regarding the number of shares sold at each separate price.

F2: Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.